Teva Pharmaceutical | PBS NewsHour
Teva suffers trial loss in New York's landmark opioid case | Fierce Pharma
Teva to pay $85m to Oklahoma over opioid case | Financial Times
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Judge approves $85 million opioid settlement with Teva | CNN
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Trial set to open in massive US opioid lawsuit also targeting Israel's Teva | The Times of Israel
Teva to Pay Oklahoma $85 Million to Avoid Trial Over Opioid Marketing
New York Opioid Trial: Allergan Settlement Leaves Teva as Last Target - Bloomberg
Teva agrees to pay $225m to settle opioid claims in Texas
Teva Pharmaceuticals found liable for role in New York opioid epidemic - UPI.com
Teva boss hits out at opioid lawsuits | Financial Times
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News
Teva Planning Swift Appeal of Opioid Judgement in New York | BioSpace
UPDATED: Teva forks over $225M to settle Texas opioid suit | Fierce Pharma
Teva Pharmaceuticals Takes Hit in New York Opioid Case
Drugmaker Teva fueled opioid addiction in New York, jury finds - The Jerusalem Post
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
New York jury holds drug firm Teva liable in opioid crisis
Rhode Island takes Teva to trial in multibillion-dollar opioid case | Reuters
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
Teva Offers Drugs Valued at $23 Billion to End Opioid Suits | IndustryWeek
Teva's generic naloxone nasal spray approved
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
Drug firm ruled liable in 6-month opioid trial
Teva found liable for fueling opioid addiction in New York
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
